StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms
Recruiting · NCT06662942 · Registry updated 2024-11-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, female reproductive system disorder, vulvar disease, vulvar lichen sclerosus | Recruiting | Phase 1 | 2024-11-08 | NCT06662942 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Andrew T. Goldstein, MD | 1 |
| Stratpharma AG | 4 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centers for Vulvovaginal Disorders, DC | Washington D.C. | United States | 1 |
| Centers for Vulvovaginal Disorders, FL | Tampa | United States | 1 |
| Centers for Vulvovaginal Disorders, NY | New York | United States | 2 |